Fetal Mesenchymal Stromal Cells: an Opportunity for Prenatal Cellular Therapy

被引：31

作者：

Sagar R. ^{[1
]}

Walther-Jallow L. ^{[2
]}

David A.L. ^{[1
,3
]}

Götherström C. ^{[2
]}

Westgren M. ^{[2
]}

机构：

[1] Institute for Women’s Health, University College London, 86-96 Chenies Mews, London

[2] Department of Clinical Science, Intervention and Technology, K57, Division of Obstetrics and Gynecology, Karolinska University Hospital Huddinge, Karolinska Institutet, Stockholm

[3] Katholieke Universiteit Leuven, Oude Markt 13, Leuven

来源：

Current Stem Cell Reports | 2018年 / 4卷 / 1期

关键词：

In utero stem cell transplantation; Mesenchymal stromal cells; Prenatal therapy;

D O I：

10.1007/s40778-018-0118-8

中图分类号：

学科分类号：

摘要：

Purpose of Review: The aim of the study is to provide an overview on the possibility of treating congenital disorders prenatally with mesenchymal stromal cells (MSCs). Recent Findings: MSCs have multilineage potential and a low immunogenic profile and are immunomodulatory and more easy to expand in culture. Their ability to migrate, engraft and differentiate, or act via a paracrine effect on target tissues makes MSCs candidates for clinical therapies. Fetal and extra-fetal MSCs offer higher therapeutic potential compared to MSCs derived from adult sources. Summary: MSCs may be safely transplanted prenatally via ultrasound-guided injection into the umbilical cord. Due to these characteristics, fetal MSCs are of great interest in the field of in utero stem cell transplantation for treatment of congenital disease. © 2018, The Author(s).

引用

页码：61 / 68

页数：7

共 50 条

[41] Expansion of Human Umbilical Cord Mesenchymal Stem/Stromal Cells in a Xenogeneic-Free System for Cellular Therapy
Orellana, M. D.
Tozzeti, P. A.
Caruso, S.
Fernandes, T. R.
Godoy, A. L.
Dotoli, G.
Palma, P. V.
Haddad, S. K.
Cunha, G. D.
Covas, D. T.
TRANSFUSION, 2015, 55 : 52A - 52A
[42] Immunological Characterization Of Multipotent Mesenchymal Stromal Cells. The International Society For Cellular Therapy (ISCT) Working Proposal
Krampera, Mauro
Galipeau, Jacques
Shi, Yufang
Tarte, Karin
Sensebe, Luc
BLOOD, 2013, 122 (21)
[43] Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement
Dominici, M.
Le Blanc, K.
Mueller, I.
Slaper-Cortenbach, I.
Marini, F. C.
Krause, D. S.
Deans, R. J.
Keating, A.
Prockop, D. J.
Horwitz, E. M.
CYTOTHERAPY, 2006, 8 (04) : 315 - 317
[44] IMMUNOLOGICAL CHARACTERIZATION OF MULTIPOTENT MESENCHYMAL STROMAL CELLS. THE INTERNATIONAL SOCIETY FOR CELLULAR THERAPY (ISCT) WORKING PROPOSAL
Krampera, M.
Galipeau, J.
Shi, Y.
Tarte, K.
Sensebe, L.
CYTOTHERAPY, 2014, 16 (04) : S81 - S81
[45] Transcriptomic and proteomic profiles of fetal versus adult mesenchymal stromal cells and mesenchymal stromal cell-derived extracellular vesicles
Gencer, Emine Beguem
Lor, Yuk Kit
Abomaray, Fawaz
El Andaloussi, Samir
Pernemalm, Maria
Sharma, Nidhi
Hagey, Daniel W.
Gorgens, Andre
Gustafsson, Manuela O.
Le Blanc, Katarina
Toonsi, Mawaddah Asad
Walther-Jallow, Lilian
Goetherstrom, Cecilia
STEM CELL RESEARCH & THERAPY, 2024, 15 (01)
[46] Mesenchymal stromal cells
Horwitz, Edwin M.
Andreef, Michael
Frassoni, Francesco
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2007, 13 (01) : 53 - 57
[47] Mesenchymal Stromal Cells
Szala, Stanislaw
Wisniewska, Ewa
Matuszczak, Sybilla
Czapla, Justyna
POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ, 2014, 68 : 1287 - 1298
[48] Mesenchymal stromal cells
Keating, Armand
CURRENT OPINION IN HEMATOLOGY, 2006, 13 (06) : 419 - 425
[49] The stromal activity of mesenchymal stromal cells
Wagner, Wolfgang
Saffrich, Rainer
Ho, Anthony D.
TRANSFUSION MEDICINE AND HEMOTHERAPY, 2008, 35 (03) : 185 - 193
[50] Strategies to improve the migration of mesenchymal stromal cells in cell therapy
Gaigai Li
Yang Hu
Yanfang Chen
Zhouping Tang
Brain Science Advances, 2017, (03) : 159 - 175

← 1 2 3 4 5 →